HIFLO-COPD

myAirvo 3 High Flow Nasal Therapy for COPD Patients in the Home (HIFLO-COPD) is a multi-center clinical trial to determine if high-flow nasal therapy (HFNT) delivered by myAirvo 3 increases the time to first moderate exacerbation or severe exacerbation or all-cause mortality in patients with moderate to very severe COPD.

Funder: Fisher & Paykel Healthcare.